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Diagnostic Benefit of Thyroglobulin
Measurement in Fine-Needle Aspiration
for Diagnosing Metastatic Cervical Lymph
Nodes from Papillary Thyroid Cancer:
Correlations with US Features
Objective: Our goals were to determine the added value of fine-needle aspira-
tion biopsy (FNAB)-thyroglobulin (Tg) measurements over FNAB-cytology alone
for diagnosing metastatic nodes, and to determine whether the ultrasound fea-
tures of lymph nodes can be used to identify lymph nodes that may benefit from
FNAB-Tg measurement in patients with papillary thyroid cancer.
Materials and Methods: We retrospectively evaluated 76 surgically proven
cervical lymph nodes. Twenty-nine patients were awaiting surgery and 18
patients had undergone thyroid surgery for papillary thyroid cancer. Ultrasound-
guided FNAB and Tg measurements were performed and the ultrasound features
were evaluated.
Results: The accuracies, sensitivities, and specificities of FNAB-cytology,
FNAB-Tg, and combined FNAB-Tg/cytology were 90%, 80%, and 100%; 92%,
95%, and 90%; and 93%, 96%, and 90%, respectively. The diagnostic sensitivity
of FNAB-Tg for metastatic nodes was significantly higher than that of FNAB-cytol-
ogy (p = 0.011). Furthermore, combined FNAB-Tg/cytology significantly
increased sensitivity (p = 0.002) and accuracy (p = 0.03) as compared with
FNAB-cytology.
Conclusion: Combined FNAB-Tg/cytology is significantly more sensitive and
accurate at detecting metastatic nodes than FNAB-cytology alone. FNAB-Tg was
better at diagnosing metastases in small lymph nodes.
he preoperative diagnosis of metastatic nodes is important for determin-
ing the optimal surgical strategy in patients with papillary thyroid
carcinoma (PTC). When metastatic nodes are suspected by preoperative
ultrasound (US) assessment, US fine-needle aspiration biopsy (FNAB) is recommended
for the histological diagnosis of metastatic nodes in patients awaiting thyroid surgery
(1). Serum thyroglobulin (Tg) assays and US are routinely recommended for the
surveillance of recurrences after the surgical treatment of differentiated thyroid
carcinoma (1). US-FNAB is widely used for the cytological diagnosis of lymph node
metastasis from PTC preoperatively, and for determining locoregional tumor
recurrence after thyroid surgery.
Thyroglobulin assessment in needle washout after fine-needle aspiration of
suspicious lymph nodes is useful for the early diagnosis of lymph node metastases
originating from differentiated thyroid cancer, and it is more sensitive and accurate at
detecting metastatic nodes than cytology, especially in cystic nodal metastases (2-10).
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THowever, it is unclear whether FNAB-Tg measurements
should be routinely accompanied by US-guided FNAB
cytology for the diagnosis of metastatic nodes in patients
with PTC, and it is unclear whether US features of lymph
nodes may help select patients who may benefit from
FNAB-Tg measurements compared with FNAB-cytology
alone.
We designed this retrospective study to determine the
added value of FNAB-Tg measurements over FNAB-
cytology alone for diagnosing metastatic nodes, and to
determine whether the US features of lymph nodes in
patients with PTC can be used to identify lymph nodes that
may benefit from FNAB-Tg measurements compared with
FNAB cytology alone.
MATERIALS AND METHODS
Patients
During a 12-month period, US-FNAB-cytology and
FNAB-Tg measurements of suspected metastatic nodes
were performed in 161 consecutive PTC patients at two
institutions (Seoul National University Hospital and the
thyroid clinic at Daerim Saint Mary’s Hospital). The institu-
tional review board approved this retrospective study and
waived the requirement for informed consent.
US-FNAB and Tg measurements were performed at
cervical nodes suspicious for metastasis by US, in patients
that underwent US for the preoperative evaluation of
suspected thyroid carcinoma, or for the postoperative
surveillance of tumor recurrence. Lymph nodes for FNAB-
cytology and FNAB-Tg were selected based on the
presence of the following US criteria: hyperechogenicity,
cystic changes, calcification, abnormal vascularity, hetero-
geneous echogenicity, a round shape
(longitudinal/transverse diameter ratio < 1.5), loss of
echogenic hilum, and a lymph node with a diameter
exceeding 6 mm (11-14).
Of the 161 PTC patients, a total of 76 surgically proven
cervical lymph nodes found in 47 patients (47 nodes in 30
patients awaiting thyroid surgery and 29 nodes in 17
patients being followed after thyroid surgery) were
included in this study. One hundred fourteen patients were
excluded because they underwent surgery or surgical neck
dissection. In all 47 patients, preoperative skin marking
was performed for lymph nodes where FNAB was
performed. Surgeons were aware of the US, cytology, and
FNAB-Tg findings and removed all skin-marked lymph
nodes. In postoperative patients, a second operation was
performed only when FNAB-cytology or FNAB-Tg results
suggested metastatic nodes. During the first operation in
patients with PTC established by FNAB-cytology, surgical
neck dissections were performed on a level-by-level basis
based on preoperative or intraoperative clinical palpation,
US features, FNAB cytology, and Tg results.
Ultrasonography, Fine-Needle Aspiration Biopsy-
Cytology, and Thyroglobulin Measurements
US examinations were performed by experienced radiol-
ogists in all 47 patients before surgery using a 10-12 MHz
linear transducer (Acuvix, Medison, Korea; iU22, Philips
Medical Systems, Bothell, WA). US examination was
performed on both thyroid lobes and the neck, including
all neck levels (level I to level VI) and the supraclavicular
fossa. We prospectively assessed the US features of lymph
nodes and determined the presence of suspected nodal
metastasis using US criteria. The US features of suspected
metastatic nodes were also recorded.
US-FNAB was performed on metastatic nodes
determined by US criteria using a free-hand technique with
a 21-23 gauge needle. Biopsy needle content was expelled
onto a slide and smeared using a second slide. Slides were
fixed in 95% ethanol, Papanicolaou-stained, and read by
an experienced cytopathologist. Immediately after aspira-
tion biopsy, the needle used was washed with 0.5-1 mL of
normal saline solution (final volume 1 mL). These washout
samples were sent for Tg assays. Serous fluid aspirates
were sent directly for assaying.
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Fig. 1. 52-year-old man with recurrent papillary thyroid
carcinoma.
US (transverse view) shows heterogeneous and hyperechoic
elongated lymph node (arrow) with focal cystic change
(arrowhead) in left lateral neck (level IV). Maximal and minimal
diameters were 9 mm and 4 mm, respectively. Result of US-fine-
needle aspiration biopsy cytology was suboptimal (mainly blood),
but measured Thyroglobulin from aspirate of node was 2,640
ng/ml.Analysis of Fine-Needle Aspiration Biopsy Cytology
and Fine-Needle Aspiration Biopsy-Thyroglobulin
Data
Fine-needle aspiration biopsy-cytology results were
categorized as inadequate, negative (reactive lymph node
or some other benign lymphadenitis), or positive for
metastatic papillary carcinoma. When the measured
FNAB-Tg level was greater than the serum Tg level, we
deemed the lymph node positive for metastasis from PTC.
In six preoperative patients whose serum Tg was not
measured before surgery, we used an FNAB-Tg cutoff
level of 36 ng/ml for determining positivity (8). Final
lymph node status was determined from histology reports
of surgical lymph node specimens. FNAB-cytology and
FNAB-Tg results were subdivided into two groups for
surgically proven metastatic nodes: the FNAB-Tg benefit
group (FNAB-Tg positive and FNAB-cytology negative)
and the no FNAB-Tg benefit group (FNAB-Tg positive and
FNAB-cytology positive, FNAB-Tg negative and FNAB-
cytology negative, and FNAB-Tg negative and FNAB-
cytology positive). We also assessed and compared the US
features of these two groups.
Statistics
Statistical analysis was performed using SPSS-PC
(Version 10.0 1999; SPSS, Chicago, IL). The sensitivities,
specificities, positive predictive values, negative predictive
values, and accuracies of FNAB-Tg and FNAB-cytology for
predicting the presence of metastases were determined
using node-by-node analysis. To assess the diagnostic
accuracy of combined FNAB-cytology and FNAB-Tg,
lymph node metastasis was deemed present when either
FNAB-Tg or FNAB-cytology was positive. The McNemar’s
test was used to compare the sensitivities, specificities, and
accuracies of FNAB-Tg and FNAB-cytology with respect to
metastatic node detection. Patients were divided into two
groups according to the presence or absence of FNAB-Tg
benefit. Differences between the groups with respect to the
presence of FNAB-Tg were assessed using Fischer’s exact
test. Differences between maximal and minimal diameters
of lymph nodes in the two groups were assessed using the
Student’s t test. P-values < 0.05 were considered statisti-
cally significant differences.
RESULTS
Fifty-six (74%) of the 76 nodes were metastatic and 20
were benign lesions (reactive lymph node - 18, tuberculous
lymphadenitis - 1, and remnant thyroid tissue - 1) by
histology, and included central neck nodes (n = 8) and
lateral neck nodes (n = 68). Preoperative serum Tg was
measured in 42 patients but not in six patients who were
awaiting initial thyroid surgery. Tg antibodies were
measured in only 18 patients.
Tables 1 and 2 demonstrate the diagnostic accuracies of
FNAB-cytology, FANB-Tg, and combined FNAB-
Tg/cytology for metastatic nodes from PTC. The results of
FNAB-cytology were inadequate in three, negative in 28,
and positive for malignancy in 45. For 56 metastatic nodes,
FNAB-cytology detected 45 (80.4%), FNAB-Tg detected
53 (94.6%), and combined FNAB-cytology/Tg detected 54
(96.4%). The sensitivities of FNAB-Tg and FNAB-
cytology/Tg were significantly higher than that of FNAB-
cytology alone (p = 0.011) (Table 3). Although the
diagnostic accuracy of FNAB-Tg was not significantly
higher than FNAB-cytology alone, that of combined
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Table 2. Diagnostic Accuracies of FNAB-Tg, FNAB-Cytology, and Combined FNAB-Tg/Cytology
Tool
Diagnostic Value
Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
FNAB-Tg 94.6 090 96.3 85.7 92.3
FNAB-cytology 80.4 100 .100 64.5 90.1
Combined FNAB-Tg/cytology 96.4 090 96.4 0.90 93.2
Note.─ FNAB = fine-needle aspiration biopsy, Tg = thyroglobulin, PPV = positive predictive value, NPV = negative predictive value, FNAB-Tg/cytology = 
combined results of FNAB-Tg and FNAB-cytology.
Table 1. FNAB-Tg, FNAB-Cytology, FNAB-Tg/Cytology, and Surgical Pathology Results for 76 Cervical Lymph Nodes
Pathology
FNAB-Tg FNAB-Cytology Combined FNAB-Tg/Cytology
Test (-) Test (+) Test (-) Test (+) Test (-) Test (+)
Metastasis (-)1 8 022 0001 802
Metastasis (+) 035 31 14 5025 4
Note.─ FNAB = fine-needle aspiration biopsy, Tg = thyroglobulinFNAB-cytology/Tg was higher than FNAB-cytology (p =
0.03). In benign lymph nodes (n = 20), FNAB-Tg levels
ranged from below 0.5 to 14,640 ng/ml. In metastatic
lymph nodes (n = 56), FNAB-Tg levels ranged from 0.5 to
above 25,000 ng/ml. Except for two false positive FNAB-
Tg cases, the FNAB-Tg levels of all benign lymph nodes
were below 2.0 ng/ml. Of the three false negative FNAB-
Tg cases, cytology results of FNAB-cytology were negative
for malignancy in two cases and positive in one. The two
false positive FNAB-Tg cases included one case of remnant
thyroid tissue (FNAB Tg 14,640 and serum Tg < 1.0 ng/ml)
and one level IV lymph node (FNAB Tg 82 ng/ml and
serum Tg 51 ng/ml). The concordance rate between FNAB-
cytology and FNAB-Tg was 84% (64 of 76 nodes). There
were 12 discordant cases: FNAB-Tg positive and FNAB-
cytology negative in 11 lymph nodes and FNAB-Tg
negative and FNAB-cytology positive in one lymph node.
Table 4 demonstrates the incidences of US criteria for
surgically proven benign and metastatic nodes. Although
FNAB-Tg was positive for all cystic lymph nodes, FNAB-
cytology provided a false negative result for three of
eleven cystic nodes. The false negative rate of FNAB-
cytology was higher for cystic lymph nodes than for lymph
nodes without cystic change, but this was not significant
(30% and 19%, respectively; p = 0.32). No statistically
significant difference was found between lymph nodes
with or without FNAB-Tg benefit with respect to US
features (p > 0.05), and US features did not significantly
predict the FNAB-Tg benefit group (Table 5). The mean
maximal and minimal diameters of nodes were not signifi-
cantly different in lymph node groups with or without
FNAB-Tg benefit (maximal diameter 1.03-0.59 vs. 1.00-
0.47 and minimal diameter 0.38-0.09 vs. 0.47-0.21, p =
0.8 and p = 0.9, respectively). However, FNAB-Tg benefit
was only found for lymph nodes with a minimal diameter
of less than 5 mm, and nodes in the FNAB-Tg benefit
group tended to be smaller (less than 5 mm in minimal
diameter) than nodes in the no FNAB-Tg benefit group
(100% vs. 68%, p = 0.09). The positive predictive value of
the US size criterion (< minimal diameter of 5 mm) for
FNAB-Tg benefit was 20% and its negative predictive
value was 100%.
DISCUSSION
This study demonstrates that combined FNAB-
Tg/cytology is more sensitive and accurate for the
detection of metastatic lymph nodes from PTC than
FNAB-cytology alone. US-guided FNAB-cytology is more
accurate than US, CT, and MRI for the detection of
metastatic cervical nodes in head and neck malignancies
(15). US-guided FNAB-cytology has high sensitivity (57-
98%), specificity (92.9-100%), and accuracy (89-97%) for
the detection of metastatic cervical lymph nodes in general
head and neck malignancies (16-20). Moreover, FNAB-
cytology has a sensitivity of 55-85%, a specificity of 90-
100%, and an accuracy of 73-77% for the diagnosis of
metastatic cervical lymph nodes from thyroid carcinoma
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Table 4. US Features of 76 Cervical Lymph Nodes
No. US Features Total (n = 76) Metastasis (n = 56) Benign (n = 20)
1 Hyperechogenicity 37 (48.6%) 31 (55.3%) 6 (30%)
2 Cystic change 11 (14.4%) 11 (19.6%) 0 (0%)
3 Calcification 16 (21%) 16 (28.5%) 0 (0%)
4 Abnormal vascularity 10 (13.1%) 07 (12.5%) 3 (15%)
5 Heterogeneous echogenicity 09 (11.8%) 06 (10.7%) 3 (15%)
6 Round shape (L/T ratio < 1.5) 02 (2.6%) 00 (0%) 2 (10%)
7 Absence of echogenic hilum 13 (17.1%) 06 (10.7%) 7 (35%)
8 Minimal diameter > 6 mm 15 (19.6%) 13 (23.2%) 2 (10%)
Note.─ L/T = longitudinal/transverse diameter ratio
Table 3. Statistical Analysis for Assessment of Cervical Node Metastasis by FNAB-Tg, FNAB-Cytology, and Combined 
FNAB-Tg/Cytology
Tool
Diagnostic Value
Sensitivity Specificity Accuracy
FNAB-Tg vs. FNAB-cytology 0.011 0.5 0.092
Combined FNAB-Tg/cytology vs. FNAB-cytology 0.002 0.5 0.03
Note.─ FNAB = fine-needle aspiration biopsy, Tg = thyroglobulin(8, 10, 21). In thyroid carcinoma, FNAB-Tg is more
sensitive and has a higher negative predictive value than
FNAB-cytology (2, 3, 22), and FNAB-Tg/cytology
increased accuracy, sensitivity, and specificity (13, 14).
These results are consistent with those of the present study.
FNAB-Tg/cytology significantly increased sensitivity and
accuracy for the detection of metastatic nodes from PTC as
compared with FNAB-cytology.
Fine-needle aspiration biopsy-Tg measurements enhance
the diagnostic accuracy of metastasis to nodes from differ-
entiated thyroid carcinoma as compared with FNAB-
cytology alone, and in previous studies the benefit derived
ranged from 8-43% (8-10). In this study, the benefit was
14%. Therefore, routine FNAB-Tg testing may not be
necessary when FNAB-cytology is performed on metasta-
tic nodes suspected by US from the standpoint of cost-
effectiveness. Moreover, although we sought to identify
US features capable of predicting FNAB-Tg benefit, no US
feature was identified as a statistically significant predictor
for FNAB-Tg benefit. Nevertheless, FNAB-Tg benefit was
found only for nodes with a minimal axial diameter of less
than 5 mm. The benefit of FNAB-Tg for small lymph nodes
is probably due to the fact that these nodes are relatively
difficult to aspirate and difficult to sample by FNAB, and
the sampled cytology results may be difficult to interpret
(23). Previous studies (2, 10) have reported high false
negative rates for FNAB-cytology and greater benefit for
FNAB-Tg in cystic metastatic nodes. In the present study,
however, the benefit of FNAB-Tg was not significantly
different for cystic and non-cystic nodes, which may be
explained by the fact that the majority of cystic metastatic
nodes included in our study showed only partial cystic
changes. Because PTC may manifest predominantly or
almost entirely as a cystic nodal mass mimicking a cyst
(24), FNAB-Tg may be beneficial in lymph nodes with
extensive cystic changes.
Although FNAB-Tg is obviously more sensitive than
FNAB-cytology, discordant FNAB-Tg negative and FNAB-
cytology positive cases could account for 2% and 6% of
nodes examined (8, 9), which is similar to the 1% (1 of 76)
we obtained. The reason for negative FNAB-Tg and
positive FNAB-cytology discordances is unclear, though it
might be related to small remnant aspirated tissue in
needles used for Tg measurements or to technical errors. In
one of the two cases with a false positive FNAB-Tg result,
high TG levels were caused by remnant thyroid tissue,
which was misdiagnosed as a recurrent tumor on the
operation bed. Cautious interpretation of positive FNAB-
Tg results is needed for central neck nodes in postoperative
patients because remnant thyroid tissue may mimic locally
recurrent tumors on the operation bed by US. However,
the cause of the false positive result in the other case is
unclear. The presence of false positive and false negative
results in FNAB-Tg indicates that it should be used with
FNAB-cytology instead of replacing FNAB-cytology.
Several limitations of the present study should be consid-
ered. First, the number of patients recruited was relatively
small. Second, we could not use serum Tg level as a cut-off
value for determining positive FNAB-Tg in six patients
that did not undergo serum Tg testing preoperatively.
However, false negative FNAB-Tg results were not
influenced by the relatively high absolute Tg cut-off level
in patients that did not undergo serum Tg testing, because
the FNAB-Tg levels were less than 1 ng/ml in all FNAB-Tg
false negative cases.
In conclusion, combined FNAB-cytology/Tg is more
sensitive and accurate for the diagnosis of metastatic
cervical lymph nodes from PTC than FNAB-cytology
Jeon et al.
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Table 5. Cases of FNAB-Tg Benefit and Corresponding US
Features
US Finding Tg Benefit P value
(+) (-)
Hyperechogenicity
(+) 3 28 0.44
(-)5 2 0
Cystic change
(+) 3 08 0.18
(-)5 4 0
Calcification
(+) 3 13 0.67
(-)5 3 5
Abnormal vascularity
(+) 1 06 1.00
(-)7 4 2
Heterogeneous echogenicity
(+) 0 06 0.57
(-)8 4 2
Round shape (L/T < 1.5)
(+) 0 00
(-)8 4 8
Absence of echogenic hilum
(+) 1 05 1.00
(-)7 4 3
Minimal diameter
> 6 mm
(+) 1 12 0.66
(-)7 3 6
5 mm
(+) 0 15 0.09
(-)8 3 3
Note.─ FNAB = fine-needle aspiration biopsy, Tg = thyroglobulin, L/T = 
longitudinal/transverse diameter ratioalone. Although no US feature significantly predicted
FNAB-Tg benefit, FNAB-Tg testing provided significant
benefit over FNAB-cytology when lymph nodes have a
minimal axial diameter of less than 5 mm.
References
1. American thyroid association guideline. Management guidelines
for patients with thyroid nodules and differentiated thyroid
cancer. Thyroid 2006;16:1-33
2. Cignarelli M, Ambrosi A, Marino A, Lamacchia O, Campo M,
Picca G, et al. Diagnostic utility of thyroglobulin detection in
fine-needle aspiration of cervical cystic metastatic lymph nodes
from papillary thyroid cancer with negative cytology. Thyroid
2003;13:1163-1167
3. Baskin HJ. Detection of recurrent papillary thyroid carcinoma
by thyroglobulin assessment in the needle washout after fine-
needle aspiration of suspicious lymph nodes. Thyroid
2004;14:959-963
4. Frasoldati A, Toschi E, Zini M, Flora M, Caroggio A, Dotti C, et
al. Role of thyroglobulin measurement in fine-needle aspiration
biopsies of cervical lymph nodes in patients with differentiated
thyroid cancer. Thyroid 1999;9:105-111
5. Lee MJ, Ross DS, Mueller PR, Daniels GH, Dawson SL,
Simeone JF. Fine-needle biopsy of cervical lymph nodes in
patients with thyroid cancer: a prospective comparison of
cytopathologic and tissue marker analysis. Radiology
1993;187:851-854
6. Pacini F, Fugazzola L, Lippi F, Ceccarelli C, Centoni R, Elisei R,
et al. Detection of thyroglobulin in fine needle aspirates of
nonthyroidal neck masses: a clue to the diagnosis of metastatic
differentiated thyroid cancer. J Clin Endocrinol Metab
1992;74:1401-1404
7. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti
JS. Clinical impact of thyroglobulin (Tg) and Tg autoantibody
method differences on the management of patients with differ-
entiated thyroid carcinomas. J Clin Endocrinol Metab
2005;90:5566-5575
8. Uruno T, Miyauchi A, Shimizu K, Tomoda C, Takamura Y, Ito
Y, et al. Usefulness of thyroglobulin measurement in fine-needle
aspiration biopsy specimens for diagnosing cervical lymph node
metastasis in patients with papillary thyroid cancer. World J
Surg 2005;29:483-485
9. Snozek CL, Chambers EP, Reading CC, Sebo TJ, Sistrunk JW,
Singh RJ, et al. Serum thyroglobulin, high-resolution ultrasound,
and lymph node thyroglobulin in diagnosis of differentiated
thyroid carcinoma nodal metastases. J Clin Endocrinol Metab
2007;92:4278-4281
10. Cunha N, Rodrigues F, Curado F, Ilheu O, Cruz C, Naidenov P,
et al. Thyroglobulin detection in fine-needle aspirates of cervical
lymph nodes: a technique for the diagnosis of metastatic differ-
entiated thyroid cancer. Eur J Endocrinol 2007;157:101-107
11. Ahuja AT, Chow L, Chick W, King W, Metreweli C. Metastatic
cervical nodes in papillary carcinoma of the thyroid: ultrasound
and histological correlation. Clin Radiol 1995;50:229-231
12. Schlumberger M, Berg G, Cohen O, Duntas L, Jamar F, Jarzab
B, et al. Follow-up of low-risk patients with differentiated
thyroid carcinoma: a European perspective. Eur J Endocrinol
2004;150:105-112
13. Rosario PW, de Faria S, Bicalho L, Alves MF, Borges MA,
Purisch S, et al. Ultrasonographic differentiation between
metastatic and benign lymph nodes in patients with papillary
thyroid carcinoma. J Ultrasound Med 2005;24:1385-1389
14. Na DG, Lim HK, Byun HS, Kim HD, Ko YH, Baek JH.
Differential diagnosis of cervical lymphadenopathy: usefulness
of color Doppler sonography. AJR Am J Roentgenol
1997;168:1311-1316
15. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer
CJ, Snow GB. Modern imaging techniques and ultrasound-
guided aspiration cytology for the assessment of neck node
metastases: a prospective comparative study. Eur Arch
Otorhinolaryngol 1993;250:11-17
16. Baatenburg de Jong RJ, Rongen RJ, Verwoerd CD, van
Overhagen H, Lameris JS,Knegt P. Ultrasound-guided fine-
needle aspiration biopsy of neck nodes. Arch Otolaryngol Head
Neck Surg 1991;117:402-404
17. van den Brekel MW, Stel HV, Castelijns JA, Croll GJ, Snow
GB. Lymph node staging in patients with clinically negative
neck examinations by ultrasound and ultrasound-guided aspira-
tion cytology. Am J Surg 1991;162:362-366
18. Takashima S, Sone S, Nomura N, Tomiyama N, Kovayashi T,
Nakamura H. Nonpalpable lymph nodes of the neck: assessment
with US and US-guided fine-needle aspiration biopsy. J Clin
Ultrasound 1997;25:283-292
19. van den Brekel MW, Reitsma LC, Quak JJ, Smeele LE, van der
Linden JC, Snow GB, et al. Sonographically guided aspiration
cytology of neck nodes for selection of treatment and follow-up
in patients with N0 head and neck cancer. AJNR Am J
Neuroradiol 1999;20:1727-1731
20. Knappe M, Louw M, Gregor RT. Ultrasonography-guided fine-
needle aspiration for the assessment of cervical metastases. Arch
Otolaryngol Head Neck Surg 2000;126:1091-1096
21. Sutton RT, Reading CC, Charboneau JW, James EM, Grant CS,
Hay ID. US-guided biopsy of neck masses in postoperative
management of patients with thyroid cancer. Radiology
1998;168:769-772
22. Schlumberger M, Pacini F, Wiersinga WM, Toft A, Smith JW,
Sanchez Franco F, et al. Follow-up and management of differen-
tiated thyroid carcinoma: a European perspective in clinical
practice. Eur J Endcorinol 2004;151:539-548
23. Hall TL, Layfield LJ, Philippe A, Rosenthal DL. Sources of
diagnostic error in fine needle aspiration of the thyroid. Cancer
1989;63:718-725
24. Ahuja A, Ng CF, King W, Metreweli C. Solitary cystic nodal
metastasis from occult papillary carcinoma of the thyroid
mimicking a branchial cyst: a potential pitfall. Clin Radiol
1998;53:61-63
Thyroglobulin Measurement and Fine Needle Aspiration for Detecting Cervical Lymph Node Metastasis from Papillary Thyroid Cancer
Korean J Radiol 10(2), April 2009 111